Table of Contents

1. Introduction

 1.1 Market Definition & Scope

 1.2 Research Assumptions & Abbreviations

 1.3 Research Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Component

  2.3.2 Market Size By Application

  2.3.3 Market Size By End User

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Material Suppliers

  3.4.2 Manufacturers

  3.4.3 Distributors/Suppliers

  3.4.4 Customers/End-Users

 3.5 Industry Life Cycle Assessment

 3.6 Parent Market Overview

 3.7 Market Risk Assessment

4. Statistical Insights & Trends Reporting

4.1 Pricing Analysis & Market Metrics

  4.1.1 Pricing Models: Subscription-based AI platform pricing, licensing for biotech software tools, pay-per-analysis models, and enterprise collaboration agreements

  4.1.2 Average Pricing Metrics: Cost per AI-enabled drug discovery project, genomic analysis workflow, and predictive modeling solution

  4.1.3 Cost Structure Breakdown: Cloud computing, algorithm development, data acquisition, computational biology infrastructure, and talent costs

  4.1.4 Price Benchmarking Metrics: AI-assisted biotechnology platforms vs traditional wet-lab-only research workflows

  4.1.5 Monetization Trends: Shift toward AI-driven drug discovery platforms and data-as-a-service biotech ecosystems

4.2 Technology & Computational Metrics

  4.2.1 Machine Learning Metrics: Adoption of supervised, unsupervised, and reinforcement learning in biotech workflows

  4.2.2 Deep Learning Metrics: Neural network utilization in protein modeling and molecular prediction

  4.2.3 Genomics Processing Metrics: AI-based genome sequencing interpretation efficiency

  4.2.4 Computational Biology Metrics: Simulation accuracy in drug discovery and bioinformatics pipelines

  4.2.5 NLP Metrics: Extraction of biomedical insights from research papers and clinical records

4.3 Drug Discovery & Development Metrics

  4.3.1 Target Identification Metrics: AI-driven identification of biological targets for therapeutic development

  4.3.2 Molecule Design Metrics: Generative AI usage in novel drug candidate creation

  4.3.3 Screening Efficiency Metrics: Reduction in compound screening time using AI models

  4.3.4 Clinical Trial Optimization Metrics: AI-driven patient selection and trial design improvements

  4.3.5 Drug Repurposing Metrics: Identification of new therapeutic uses for existing drugs

4.4 Bioinformatics & Data Metrics

  4.4.1 Genomic Data Metrics: AI processing of large-scale genomic datasets

  4.4.2 Proteomics Metrics: Protein structure prediction and interaction mapping efficiency

  4.4.3 Data Integration Metrics: Multi-omics (genomics, transcriptomics, proteomics) convergence

  4.4.4 Data Volume Metrics: Expansion of biomedical datasets used for AI training

  4.4.5 Data Accuracy Metrics: Reduction in error rates in biological data interpretation

5. Artificial Intelligence (AI) in Biotechnology Market Segmental Analysis & Forecast, By Component, 2022–2035, Value (Usd Billion)

5.1 Introduction

 5.2 Software

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022–2035

 5.3 Hardware

 5.4 Services

6. Artificial Intelligence (AI) in Biotechnology Market Segmental Analysis & Forecast, By Application, 2022–2035, Value (Usd Billion)

    6.1 Introduction

 6.2 Drug Discovery & Development

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022–2035

 6.3 Clinical Trials & Optimization

 6.4 Medical Imaging

 6.5 Diagnostics

 6.6 Others

7. Artificial Intelligence (AI) in Biotechnology Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (Usd Billion)

    7.1 Introduction

 7.2 Pharmaceutical Companies

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022–2035

 7.3 Biotechnology Companies

 7.4 Academic & Research Institutes

 7.5 Healthcare Providers

 7.6 CRO & CDMO

 7.7 Others

8. Artificial Intelligence (AI) in Biotechnology Market Segmental Analysis & Forecast By Region, 2022–2035, Value (Usd Billion)

8.1 Introduction

8.2 North America

 8.2.1 Key Trends

 8.2.2 Artificial Intelligence (AI) in Biotechnology Market Size & Forecast, By Component, 2022–2035

 8.2.3 Artificial Intelligence (AI) in Biotechnology Market Size & Forecast, By Application, 2022–2035

 8.2.4 Artificial Intelligence (AI) in Biotechnology Market Size & Forecast, By End User, 2022–2035

 8.2.5 Artificial Intelligence (AI) in Biotechnology Market Size & Forecast, By Country, 2022–2035

  8.2.5.1 USA

  8.2.5.2 Canada

8.3 Europe

 8.3.1 Key Trends

 8.3.2 Artificial Intelligence (AI) in Biotechnology Market Size & Forecast, By Component, 2022–2035

 8.3.3 Artificial Intelligence (AI) in Biotechnology Market Size & Forecast, By Application, 2022–2035

 8.3.4 Artificial Intelligence (AI) in Biotechnology Market Size & Forecast, By End User, 2022–2035

 8.3.5 Artificial Intelligence (AI) in Biotechnology Market Size & Forecast, By Country, 2022–2035

  8.3.5.1 Germany

  8.3.5.2 UK

  8.3.5.3 France

  8.3.5.4 Italy

  8.3.5.5 Spain

  8.3.5.6 Russia

  8.3.5.7 Poland

  8.3.5.8 Rest of Europe

8.4 Asia-Pacific

 8.4.1 Key Trends

 8.4.2 Artificial Intelligence (AI) in Biotechnology Market Size & Forecast, By Component, 2022–2035

 8.4.3 Artificial Intelligence (AI) in Biotechnology Market Size & Forecast, By Application, 2022–2035

 8.4.4 Artificial Intelligence (AI) in Biotechnology Market Size & Forecast, By End User, 2022–2035

 8.4.5 Artificial Intelligence (AI) in Biotechnology Market Size & Forecast, By Country, 2022–2035

  8.4.5.1 China

  8.4.5.2 India

  8.4.5.3 Japan

  8.4.5.4 South Korea

  8.4.5.5 Australia

  8.4.5.6 ASEAN Countries

  8.4.5.7 Rest of Asia-Pacific

8.5 Latin America

 8.5.1 Key Trends

 8.5.2 Artificial Intelligence (AI) in Biotechnology Market Size & Forecast, By Component, 2022–2035

 8.5.3 Artificial Intelligence (AI) in Biotechnology Market Size & Forecast, By Application, 2022–2035

 8.5.4 Artificial Intelligence (AI) in Biotechnology Market Size & Forecast, By End User, 2022–2035

 8.5.5 Artificial Intelligence (AI) in Biotechnology Market Size & Forecast, By Country, 2022–2035

  8.5.5.1 Brazil

  8.5.5.2 Argentina

  8.5.5.3 Mexico

  8.5.5.4 Colombia

  8.5.5.5 Rest of Latin America

8.6 Middle East & Africa

 8.6.1 Key Trends

 8.6.2 Artificial Intelligence (AI) in Biotechnology Market Size & Forecast, By Component, 2022–2035

 8.6.3 Artificial Intelligence (AI) in Biotechnology Market Size & Forecast, By Application, 2022–2035

 8.6.4 Artificial Intelligence (AI) in Biotechnology Market Size & Forecast, By End User, 2022–2035

 8.6.5 Artificial Intelligence (AI) in Biotechnology Market Size & Forecast, By Country, 2022–2035

  8.6.5.1 UAE

  8.6.5.2 Saudi Arabia

  8.6.5.3 Qatar

  8.6.5.4 Egypt

  8.6.5.5 South Africa

  8.6.5.6 Rest of Middle East & Africa

9. Competitive Landscape

 9.1 Key Players' Positioning

 9.2 Competitive Developments

  9.2.1 Key Strategies Adopted (%), By Key Players, 2025

  9.2.2 Year-Wise Strategies & Development, 2022–2025

  9.2.3 Number Of Strategies Adopted By Key Players, 2025

 9.3 Market Share Analysis, 2025

 9.4 Product/Service & Application Benchmarking

  9.4.1 Product/Service Specifications & Features By Key Players

  9.4.2 Product/Service Heatmap By Key Players

  9.4.3 Application Heatmap By Key Players

 9.5 Industry Start-Up & Innovation Landscape

9.6 Key Company Profiles

9.6.1 NVIDIA Corporation

 9.6.1.1 Company Overview & Snapshot

 9.6.1.2 Product/Service Portfolio

 9.6.1.3 Key Company Financials

 9.6.1.4 SWOT Analysis

9.6.2 Illumina Inc.

9.6.3 IBM Corporation

9.6.4 Recursion Pharmaceuticals

9.6.5 Insilico Medicine

9.6.6 AstraZeneca plc

9.6.7 Pfizer Inc.

9.6.8 F. Hoffmann-La Roche Ltd

9.6.9 Novartis AG

9.6.10 Sanofi S.A.

9.6.11 Amgen Inc.

9.6.12 Johnson & Johnson (Janssen)

9.6.13 Bristol-Myers Squibb Company

9.6.14 Merck & Co., Inc.

9.6.15 Gilead Sciences Inc.

9.6.16 Biogen Inc.

9.6.17 Abbott Laboratories

9.6.18 Tempus AI

9.6.19 Schrödinger Inc.

9.6.20 Exscientia plc

10. Analyst Recommendations

 10.1 SNS Insider Opportunity Map

 10.2 Industry Low-Hanging Fruit Assessment

 10.3 Market Entry & Growth Strategy

 10.4 Analyst Viewpoint & Suggestions On Market Growth

11. Assumptions

12. Disclaimer

13. Appendix

 13.1 List Of Tables

 13.2 List Of Figures